Keyword: Catalent

Catalent's new prize adding capacity to make gene therapies

Tuesday, May 21, 2019

Catalent's newly acquired Paragon Bioservices will expand its capacity to as much as 425,000 square feet to manufacture therapies for Sarepta.

Catalent expands Kentucky solid dose plant

by Eric Palmer

Monday, April 29, 2019

CDMO Catalent is adding a spray dryer to its site in Kentucky as part of a $40 million expansion.

Did Biogen learn a big lesson from its past proxy fights?

by Eric Sagonowsky

Monday, April 29, 2019

After its Alzheimer's drug flop wiped out 30% of Biogen's market cap, the company is adding three new members to its board.

News of Note—Sun Pharma slapped with Form 483

Thursday, April 25, 2019

Sun Pharma has been issued a Form 483, Catalent is investing $14 million at a facility in Germany and more manufacturing news of note.

Catalent pulls off $1.2B deal for gene therapy CDMO Paragon

by Eric Palmer

Monday, April 15, 2019

In the second major buyout of a gene therapy manufacturer in the last three weeks, Catalent snapped up Paragon Bioservices in a $1.2 billion deal.

PD-1 royalty dispute, Takeda and more—FiercePharmaAsia

by Angus Liu

Friday, April 12, 2019

Nobel laureate wants bigger PD-1 revenue cut; Takeda scouts buyers for Latin America business; Chinese genomics investor is forced out of U.S. firm.

Catalent opens second clinical supply facility in Shanghai

by Eric Palmer

Thursday, April 11, 2019

With drug development in China growing rapidly, Catalent has doubled down on its clinical supply capabilities in Shanghai.

Overcoming Manufacturing Challenges for Accelerated Approvals

Presented by:

Catalent

Wednesday, May 2, 2018

The pharmaceutical industry has experienced a trend in the number of accelerated approval designations for drugs (e.g. orphan drugs, breakthrough therapies, accelerated approvals, and FDA priority reviews) being developed.

Innovative OTC Remedies for Seasonal Flu Epidemic

Presented by:

Catalent

Thursday, March 28, 2019

How are sales of OTC drugs impacted by the severity of flu seasons?

Critical Steps for a Successful Drug Product Tech Transfer

Presented by:

Catalent

Tuesday, February 19, 2019

Contract development and manufacturing organizations (CDMOs) occupy a unique position in the pharmaceutical industry.